Hedeker Wealth LLC cut its stake in JPMorgan Chase & Co. (NYSE:JPM) by 2.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,465 shares of the financial services provider’s stock after selling 397 shares during the quarter. Hedeker Wealth LLC’s holdings in JPMorgan Chase & Co. were worth $4,529,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Redwood Park Advisors LLC acquired a new position in JPMorgan Chase & Co. in the 4th quarter valued at about $29,000. Curat Global LLC bought a new position in shares of JPMorgan Chase & Co. during the first quarter valued at $33,000. Investment Counsel Co. of Nevada acquired a new stake in JPMorgan Chase & Co. in the fourth quarter worth $37,000. Prudent Man Investment Management Inc. acquired a new stake in JPMorgan Chase & Co. in the fourth quarter worth $43,000. Finally, Measured Risk Portfolios Inc. bought a new position in shares of JPMorgan Chase & Co. in the fourth quarter valued at $44,000. 71.55% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other JPMorgan Chase & Co. news, CFO Jeremy Barnum sold 40,014 shares of JPMorgan Chase & Co. stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $250.77, for a total transaction of $10,034,310.78. Following the sale, the chief financial officer owned 18,017 shares of the company’s stock, valued at $4,518,123.09. The trade was a 68.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Linda Bammann sold 9,500 shares of JPMorgan Chase & Co. stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $250.00, for a total value of $2,375,000.00. Following the sale, the director directly owned 91,539 shares in the company, valued at $22,884,750. The trade was a 9.40% decrease in their position. The disclosure for this sale can be found here. Insiders sold 71,200 shares of company stock worth $18,060,015 over the last 90 days. Insiders own 0.47% of the company’s stock.
JPMorgan Chase & Co. Price Performance
JPMorgan Chase & Co. (NYSE:JPM – Get Free Report) last announced its quarterly earnings results on Tuesday, July 15th. The financial services provider reported $4.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.48 by $0.48. The business had revenue of $44.91 billion for the quarter, compared to the consensus estimate of $43.76 billion. JPMorgan Chase & Co. had a return on equity of 16.93% and a net margin of 20.52%. The business’s revenue was down 10.5% on a year-over-year basis. During the same quarter last year, the business posted $6.12 EPS. Sell-side analysts expect that JPMorgan Chase & Co. will post 18.1 earnings per share for the current fiscal year.
JPMorgan Chase & Co. Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Thursday, July 3rd will be paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.87%. The ex-dividend date of this dividend is Thursday, July 3rd. JPMorgan Chase & Co.’s payout ratio is currently 28.73%.
Wall Street Analyst Weigh In
JPM has been the subject of several recent research reports. TD Cowen initiated coverage on shares of JPMorgan Chase & Co. in a research note on Thursday, May 15th. They issued a “buy” rating and a $305.00 target price for the company. Wells Fargo & Company increased their price target on shares of JPMorgan Chase & Co. from $320.00 to $325.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 16th. Keefe, Bruyette & Woods raised their price target on shares of JPMorgan Chase & Co. from $327.00 to $330.00 and gave the company an “outperform” rating in a report on Wednesday, July 16th. Phillip Securities cut shares of JPMorgan Chase & Co. from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, July 16th. Finally, Robert W. Baird lowered shares of JPMorgan Chase & Co. from a “neutral” rating to an “underperform” rating and set a $235.00 price objective for the company. in a research report on Friday, June 27th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $288.68.
View Our Latest Stock Analysis on JPMorgan Chase & Co.
JPMorgan Chase & Co. Profile
JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate.
Further Reading
- Five stocks we like better than JPMorgan Chase & Co.
- Should You Invest in Penny Stocks?
- This Drone Stock Is on Sale Despite Big Army Contract
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 5 Stocks to Buy in August With Tremendous Upside Potential
- How to Read Stock Charts for Beginners
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM – Free Report).
Receive News & Ratings for JPMorgan Chase & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan Chase & Co. and related companies with MarketBeat.com's FREE daily email newsletter.